Literature DB >> 3857279

Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).

F Shirakawa, U Yamashita, H Suzuki.   

Abstract

Monocyte populations expressing HLA-DR antigens were studied in SLE patients by flow cytofluorometry with indirect immunofluorescence. Both the number of HLA-DR-positive monocytes and the expression of HLA-DR antigens on monocytes were markedly decreased in active SLE patients and were recovered to the normal level in inactive SLE patients. Because Ia-positive monocytes play a regulatory role for several immune responses, the decrease in HLA-DR-positive monocytes will result in abnormal regulations of immune responses and will play some critical role in the pathogenesis and the process of SLE.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857279

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.

Authors:  T Sasaki; S Shibata; Y Hirabayashi; Y Sekiguchi; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background.

Authors:  S Rashtak; E Marietta; S Cheng; M Camilleri; M Pittelkow; C David; J Grande; J Murray
Journal:  Lupus       Date:  2010-02-08       Impact factor: 2.911

3.  Decreased expression of adhesion molecules on monocytes in recent onset IDDM.

Authors:  S Martin; H Rothe; D Tschöpe; B Schwippert; H Kolb
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

Review 4.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

Authors:  H Tsukamoto; A Ueda; K Nagasawa; Y Tada; Y Niho
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

6.  The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus.

Authors:  H D Volk; N Sönnichsen; S Jahn; F Hiepe; E Apostoloff; R von Baehr; W Diezel
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

7.  Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.

Authors:  K R Gardiner; A D Crockard; M I Halliday; B J Rowlands
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.

Authors:  G T Spear; D M Paulnock; R L Jordan; D M Meltzer; J A Merritt; E C Borden
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

9.  Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

Authors:  Wolfgang Tillinger; Ruth Jilch; Thomas Waldhoer; Walter Reinisch; Wolfgang Junger
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

10.  T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity.

Authors:  B L Bermas; M Petri; D Goldman; B Mittleman; M W Miller; N I Stocks; C S Via; G M Shearer
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.